vs
SIERRA BANCORP（BSRR）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是SIERRA BANCORP的1.9倍（$75.5M vs $39.3M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 3.8%），SIERRA BANCORP自由现金流更多（$32.2M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 2.6%）
Sierra Bancorp是总部位于美国加利福尼亚州的地区性银行控股公司，运营Bank of the Sierra品牌，提供存款、消费贷款、商业信贷、按揭等零售及商业银行业务，主要服务加州中南部的本地社区、中小企业及个人客户。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
BSRR vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.9倍
$39.3M
营收增速更快
PBYI
高出24.0%
3.8%
自由现金流更多
BSRR
多$17.8M
$14.4M
两年增速更快
PBYI
近两年复合增速
2.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $39.3M | $75.5M |
| 净利润 | $12.9M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 43.6% | 22.7% |
| 净利率 | 40.4% | — |
| 营收同比 | 3.8% | 27.7% |
| 净利润同比 | 24.4% | — |
| 每股收益（稀释后） | $0.96 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BSRRPBYI
| Q4 25 | $39.3M | $75.5M | ||
| Q3 25 | $40.0M | $54.5M | ||
| Q2 25 | $39.2M | $52.4M | ||
| Q1 25 | $36.8M | $46.0M | ||
| Q4 24 | $37.9M | $59.1M | ||
| Q3 24 | $38.6M | $80.5M | ||
| Q2 24 | $37.8M | $47.1M | ||
| Q1 24 | $37.3M | $43.8M |
净利润BSRRPBYI
| Q4 25 | $12.9M | — | ||
| Q3 25 | $9.7M | $8.8M | ||
| Q2 25 | $10.6M | $5.9M | ||
| Q1 25 | $9.1M | $3.0M | ||
| Q4 24 | $10.4M | — | ||
| Q3 24 | $10.6M | $20.3M | ||
| Q2 24 | $10.3M | $-4.5M | ||
| Q1 24 | $9.3M | $-4.8M |
毛利率BSRRPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率BSRRPBYI
| Q4 25 | 43.6% | 22.7% | ||
| Q3 25 | 31.7% | 17.6% | ||
| Q2 25 | 36.3% | 12.7% | ||
| Q1 25 | 33.4% | 8.7% | ||
| Q4 24 | 33.3% | 22.6% | ||
| Q3 24 | 37.4% | 27.4% | ||
| Q2 24 | 37.6% | -4.6% | ||
| Q1 24 | 33.9% | -5.3% |
净利率BSRRPBYI
| Q4 25 | 40.4% | — | ||
| Q3 25 | 24.2% | 16.2% | ||
| Q2 25 | 27.1% | 11.2% | ||
| Q1 25 | 24.8% | 6.5% | ||
| Q4 24 | 34.1% | — | ||
| Q3 24 | 27.5% | 25.2% | ||
| Q2 24 | 27.2% | -9.6% | ||
| Q1 24 | 25.0% | -11.0% |
每股收益（稀释后）BSRRPBYI
| Q4 25 | $0.96 | $0.26 | ||
| Q3 25 | $0.72 | $0.17 | ||
| Q2 25 | $0.78 | $0.12 | ||
| Q1 25 | $0.65 | $0.06 | ||
| Q4 24 | $0.73 | $0.40 | ||
| Q3 24 | $0.74 | $0.41 | ||
| Q2 24 | $0.71 | $-0.09 | ||
| Q1 24 | $0.64 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $135.6M | $97.5M |
| 总债务越低越好 | $49.5M | $22.7M |
| 股东权益账面价值 | $364.9M | $130.3M |
| 总资产 | $3.8B | $216.3M |
| 负债/权益比越低杠杆越低 | 0.14× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资BSRRPBYI
| Q4 25 | $135.6M | $97.5M | ||
| Q3 25 | $95.5M | $94.4M | ||
| Q2 25 | $130.0M | $96.0M | ||
| Q1 25 | $159.7M | $93.2M | ||
| Q4 24 | $100.7M | $101.0M | ||
| Q3 24 | $132.8M | $96.7M | ||
| Q2 24 | $184.0M | $96.8M | ||
| Q1 24 | $119.2M | $107.2M |
总债务BSRRPBYI
| Q4 25 | $49.5M | $22.7M | ||
| Q3 25 | $49.5M | $34.0M | ||
| Q2 25 | $49.4M | $45.3M | ||
| Q1 25 | $49.4M | $56.7M | ||
| Q4 24 | $49.4M | $68.0M | ||
| Q3 24 | $49.4M | $79.3M | ||
| Q2 24 | $49.3M | $90.7M | ||
| Q1 24 | $49.3M | $102.0M |
股东权益BSRRPBYI
| Q4 25 | $364.9M | $130.3M | ||
| Q3 25 | $360.1M | $115.3M | ||
| Q2 25 | $355.7M | $104.7M | ||
| Q1 25 | $351.8M | $97.1M | ||
| Q4 24 | $357.3M | $92.1M | ||
| Q3 24 | $358.7M | $71.1M | ||
| Q2 24 | $350.0M | $48.5M | ||
| Q1 24 | $345.1M | $51.0M |
总资产BSRRPBYI
| Q4 25 | $3.8B | $216.3M | ||
| Q3 25 | $3.7B | $202.9M | ||
| Q2 25 | $3.8B | $194.9M | ||
| Q1 25 | $3.6B | $196.2M | ||
| Q4 24 | $3.6B | $213.3M | ||
| Q3 24 | $3.7B | $220.7M | ||
| Q2 24 | $3.7B | $205.0M | ||
| Q1 24 | $3.6B | $214.1M |
负债/权益比BSRRPBYI
| Q4 25 | 0.14× | 0.17× | ||
| Q3 25 | 0.14× | 0.30× | ||
| Q2 25 | 0.14× | 0.43× | ||
| Q1 25 | 0.14× | 0.58× | ||
| Q4 24 | 0.14× | 0.74× | ||
| Q3 24 | 0.14× | 1.12× | ||
| Q2 24 | 0.14× | 1.87× | ||
| Q1 24 | 0.14× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $33.7M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $32.2M | $14.4M |
| 自由现金流率自由现金流/营收 | 81.9% | 19.1% |
| 资本支出强度资本支出/营收 | 3.9% | 0.0% |
| 现金转化率经营现金流/净利润 | 2.61× | — |
| 过去12个月自由现金流最近4个季度 | $50.8M | $41.7M |
8季度趋势，按日历期对齐
经营现金流BSRRPBYI
| Q4 25 | $33.7M | $14.4M | ||
| Q3 25 | $14.9M | $9.7M | ||
| Q2 25 | $-35.9M | $14.1M | ||
| Q1 25 | $40.6M | $3.6M | ||
| Q4 24 | $57.2M | $15.6M | ||
| Q3 24 | $27.4M | $11.0M | ||
| Q2 24 | $620.0K | $1.0M | ||
| Q1 24 | $7.0M | $11.2M |
自由现金流BSRRPBYI
| Q4 25 | $32.2M | $14.4M | ||
| Q3 25 | $14.7M | $9.7M | ||
| Q2 25 | $-36.3M | $14.1M | ||
| Q1 25 | $40.2M | $3.6M | ||
| Q4 24 | $56.0M | $15.6M | ||
| Q3 24 | $27.3M | $11.0M | ||
| Q2 24 | $202.0K | $1.0M | ||
| Q1 24 | $6.6M | — |
自由现金流率BSRRPBYI
| Q4 25 | 81.9% | 19.1% | ||
| Q3 25 | 36.7% | 17.7% | ||
| Q2 25 | -92.6% | 26.8% | ||
| Q1 25 | 109.5% | 7.7% | ||
| Q4 24 | 147.9% | 26.4% | ||
| Q3 24 | 70.7% | 13.7% | ||
| Q2 24 | 0.5% | 2.1% | ||
| Q1 24 | 17.7% | — |
资本支出强度BSRRPBYI
| Q4 25 | 3.9% | 0.0% | ||
| Q3 25 | 0.6% | 0.0% | ||
| Q2 25 | 1.2% | 0.0% | ||
| Q1 25 | 1.0% | 0.1% | ||
| Q4 24 | 3.1% | 0.0% | ||
| Q3 24 | 0.3% | 0.0% | ||
| Q2 24 | 1.1% | 0.0% | ||
| Q1 24 | 1.0% | 0.0% |
现金转化率BSRRPBYI
| Q4 25 | 2.61× | — | ||
| Q3 25 | 1.54× | 1.10× | ||
| Q2 25 | -3.37× | 2.41× | ||
| Q1 25 | 4.46× | 1.21× | ||
| Q4 24 | 5.51× | — | ||
| Q3 24 | 2.58× | 0.54× | ||
| Q2 24 | 0.06× | — | ||
| Q1 24 | 0.75× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
